26 min
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior Goldman Sachs Exchanges
-
- Business
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
26 min